Jaime Alegrio Louro

Jaime Alegrio Louro

Auto-generated profile, based on publicly available information

Jaime Alegrio Louro

Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2017 in eLife
Verified
Journal Article
Open access
ETEva Torreira
Eva Torreira
JLJaime Alegrio Louro
Jaime Alegrio Louro
IPIrene Pazos
Irene Pazos
NGNoelia González-Polo
Noelia González-Polo
DGDavid Gil-Carton
David Gil-Carton
CFCarlos Fernández-Tornero
Carlos Fernández-Tornero
Cell growth requires synthesis of ribosomal RNA by RNA polymerase I (Pol I). Binding of initiation factor Rrn3 activates Pol I, fostering recruitment to ribosomal DNA promoters. This fundamental process must be precisely regulated to satisfy cell needs at any time. We present in vivo evidence that, when growth is arrested by nutrient deprivation, cells induce rapid clearance of Pol I–Rrn3 complexes, followed by the assembly of inactive Pol I homodimers. This dual repressive mechanism reverts upon nutrient addition, thus restoring cell growth. Moreover, Pol I dimers also form after inhibition of either ribosome biogenesis or protein synthesis. Our mutational analysis, based on the electron cryomicroscopy structures of monomeric Pol I alone and in complex with Rrn3, underscores the central role of subunits A43 and A14 in the regulation of differential Pol I complexes assembly and subsequent promoter association.

1 December 2023 in Science Advances
Verified
Journal Article
Open access
MMMarta Sanz Murillo
Marta Sanz Murillo
ASAmalia Villagran Suarez
Amalia Villagran Suarez
VDVerena Dederer
Verena Dederer
DCDeep Chatterjee
Deep Chatterjee
JLJaime Alegrio Louro
Jaime Alegrio Louro
ALAndres E. Leschziner
Andres E. Leschziner
Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial Parkinson’s disease (PD) and a risk factor for the sporadic form. Increased kinase activity was shown in patients with both familial and sporadic PD, making LRRK2 kinase inhibitors a major focus of drug development efforts. Although much progress has been made in understanding the structural biology of LRRK2, there are no available structures of LRRK2 inhibitor complexes. To this end, we solved cryo–electron microscopy structures of LRRK2, wild-type and PD-linked mutants, bound to the LRRK2-specific type I inhibitor MLi-2 and the broad-spectrum type II inhibitor GZD-824. Our structures revealed an active-like LRRK2 kinase in the type I inhibitor complex, and an inactive DYG-out in the type II inhibitor complex. Our structural analysis also showed how inhibitor-induced conformational changes in LRRK2 are affected by its autoinhibitory N-terminal repeats. The structures provide a template for the rational development of LRRK2 kinase inhibitors covering both canonical inhibitor binding modes.

28 July 2025 in Genes & Development
Verified
Journal Article
Open access
JAJaime Alegrio-Louro
Jaime Alegrio-Louro
GCGrisel Cruz-Becerra
Grisel Cruz-Becerra
GKGeorge A. Kassavetis
George A. Kassavetis
JKJames T. Kadonaga
James T. Kadonaga
ALAndres E. Leschziner
Andres E. Leschziner
The tardigrade damage suppressor (Dsup) and vertebrate high-mobility group N (HMGN) proteins bind specifically to nucleosomes via a conserved motif whose structure has not been experimentally determined. Here we used cryo-EM to show that both proteins bind to the nucleosome acidic patch via analogous arginine anchors with one molecule bound to each face of the nucleosome. We additionally used the natural promoter-containing 5S rDNA sequence for structural analysis of the nucleosome. These structures of an ancient nucleosome-binding motif suggest that there is an untapped realm of proteins with a related mode of binding to chromatin.

31 October 2025 in eLife
Verified
Journal Article
Open access
SCSiyu Chen
Siyu Chen
TBTamar Basiashvili
Tamar Basiashvili
JHJoshua Hutchings
Joshua Hutchings
MMMarta Sanz Murillo
Marta Sanz Murillo
ASAmalia Villagran Suarez
Amalia Villagran Suarez
EVElizabeth Villa
Elizabeth Villa
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Mutations in human leucine-rich repeat kinase 2 (LRRK2), a multi-domain protein containing both a kinase and a GTPase, are a leading cause of the familial form of PD. Pathogenic LRRK2 mutations increase LRRK2 kinase activity. While the bulk of LRRK2 is found in the cytosol, the protein associates with membranes where its Rab GTPase substrates are found, and under certain conditions, with microtubules. Integrative structural studies using single-particle cryo-electron microscopy and in situ cryo-electron tomography (cryo-ET) have revealed the architecture of microtubule-associated LRRK2 filaments, and that formation of these filaments requires LRRK2’s kinase to be in the active-like conformation. However, whether LRRK2 can interact with and form filaments on microtubules in its autoinhibited state, where the kinase domain is in the inactive conformation and the N-terminal LRR domain covers the kinase active site, was not known. Using cryo-ET, we show that full-length human LRRK2 can oligomerize on microtubules in its autoinhibited state. Both WT-LRRK2 and PD-linked LRRK2 mutants formed filaments on microtubules. While these filaments are stabilized by the same interfaces seen in the active-LRRK2 filaments, we observed a new interface involving the N-terminal repeats that were disordered in the active-LRRK2 filaments. The helical parameters of the autoinhibited-LRRK2 filaments are different from those reported for the active-LRRK2 filaments. Finally, the autoinhibited-LRRK2 filaments are shorter and less regular, suggesting they are less stable.

20 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SCSiyu Chen
Siyu Chen
TBTamar Basiashvili
Tamar Basiashvili
JHJoshua Hutchings
Joshua Hutchings
MMMarta Sanz Murillo
Marta Sanz Murillo
ASAmalia Villagran Suarez
Amalia Villagran Suarez
EVElizabeth Villa
Elizabeth Villa
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. Mutations in leucine-rich repeat kinase 2 (LRRK2), a multi-domain protein containing both a kinase and a GTPase, are a leading cause of the familial form of PD. Pathogenic LRRK2 mutations increase LRRK2 kinase activity. While the bulk of LRRK2 is found in the cytosol, the protein associates with membranes where its Rab GTPase substrates are found, and under certain conditions, with microtubules. Integrative structural studies using single-particle cryo-electron microscopy (cryo-EM) and in situ cryo-electron tomography (cryo-ET) have revealed the architecture of microtubule-associated LRRK2 filaments, and that formation of these filaments requires LRRK2’s kinase to be in the active-like conformation. However, whether LRRK2 can interact with and form filaments on microtubules in its autoinhibited state, where the kinase domain is in the inactive conformation and the N-terminal LRR domain covers the kinase active site, was not known. Using cryo-ET, we show that full-length LRRK2 can oligomerize on microtubules in its autoinhibited state. Both WT-LRRK2 and PD-linked LRRK2 mutants formed filaments on microtubules. While these filaments are stabilized by the same interfaces seen in the active-LRRK2 filaments, we observed a new interface involving the N-terminal repeats that were disordered in the active-LRRK2 filaments. The helical parameters of the autoinhibited-LRRK2 filaments are different from those reported for the active-LRRK2 filaments. Finally, the autoinhibited-LRRK2 filaments are shorter and less regular, suggesting they are less stable.

8 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JAJaime Alegrio-Louro
Jaime Alegrio-Louro
GCGrisel Cruz-Becerra
Grisel Cruz-Becerra
JKJames T. Kadonaga
James T. Kadonaga
ALAndres E. Leschziner
Andres E. Leschziner
The tardigrade damage suppressor (Dsup) and vertebrate high mobility group N (HMGN) proteins bind specifically to nucleosomes via a conserved motif whose structure has not been experimentally determined. Here we used cryo-EM to show that both proteins bind to the nucleosome acidic patch via analogous arginine anchors with one molecule bound to each face of the nucleosome. We additionally employed the natural promoter-containing 5S rDNA sequence for structural analysis of the nucleosome. These structures of an ancient nucle-osome-binding motif suggest that there is an untapped realm of proteins with a related mode of binding to chromatin.